跳到主要导航 跳到搜索 跳到主要内容

Umbilical Cord-Mesenchymal Stromal Cell-Derived Extracellular Vesicles Target the Liver to Improve Neurovascular Health in Type 2 Diabetes With Non-Alcoholic Fatty Liver Disease

  • Minghao Du
  • , Hao Yang
  • , Jinyun Niu
  • , Jing Huang
  • , Lihong Wang
  • , Junxiu Xi
  • , Panpan Meng
  • , Zhiyong Liu
  • , Guaiguai Ma
  • , Jiani Li
  • , Xiaoyan Liu
  • , Liang Guo
  • , Mingjun Hu
  • , Zhufang Tian
  • , Bin Liu
  • , Weiping Liu
  • , Ashok K. Shetty
  • , Shengxi Wu
  • , Andrius Baskys
  • , Qianfa Long
  • Xi'an Jiaotong University
  • Northwestern Polytechnical University Xian
  • Air Force Medical University
  • Shaanxi Lon-EV Biotechnology Limited Company
  • Northwest University China
  • Texas A&M University
  • Western University of Health Sciences

科研成果: 期刊稿件 › 文章 › 同行评审

17 引用 (Scopus)

摘要

Type 2 diabetes mellitus (T2DM) combined with non-alcoholic fatty liver disease (NAFLD) exacerbates metabolic dysregulation and neurovascular complications, presenting significant therapeutic challenges. We demonstrate, using SPECT/CT imaging, that extracellular vesicles (EVs) from mesenchymal stromal cells (MSCs) predominantly accumulate in the liver, where they deliver miR-31-5p to suppress platelet-derived growth factor B (PDGFB) produced by hepatic macrophages. This intervention impedes NAFLD progression and establishes a mechanistic link between liver repair and neurovascular improvement. Specifically, single-nucleus RNA sequencing reveals that PDGFB suppression enhances hippocampal pericyte recovery via the PDGFB-PDGFRβ axis and orchestrates the activation of growth differentiation factor 11 (GDF11), thus promoting neuroplasticity. Furthermore, AAV injections indicate that hepatic PDGFB modulation recalibrates transthyretin (TTR) dynamics, thereby restoring its neuroprotective functions and preventing its pathological deposition in the brain. These findings position MSC-EVs as a transformative therapeutic platform that leverages the liver-brain axis to address the intertwined metabolic and neurovascular complications of T2DM, offering a promising avenue for clinical translation.

源语言英语
期刊论文编号e70125
期刊Journal of Extracellular Vesicles
卷14
期7
DOI
出版状态已出版 - 7月 2025

联合国可持续发展目标

此成果有助于实现下列可持续发展目标:

  1. 可持续发展目标 3 - 良好健康与福祉
    可持续发展目标 3 良好健康与福祉

学术指纹

探究 'Umbilical Cord-Mesenchymal Stromal Cell-Derived Extracellular Vesicles Target the Liver to Improve Neurovascular Health in Type 2 Diabetes With Non-Alcoholic Fatty Liver Disease' 的科研主题。它们共同构成独一无二的学术指纹。

引用此